These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 25692091)
1. The importance of early diagnosis and treatment of kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon. Vivas-Colmenares GV; Ramirez-Villar GL; Bernabeu-Wittel J; Matute de Cardenas JA; Fernandez-Pineda I Dermatol Pract Concept; 2015 Jan; 5(1):91-3. PubMed ID: 25692091 [TBL] [Abstract][Full Text] [Related]
3. Kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon in an infant girl. Helligsø L; Mikkelsen TS; Hvas AM Clin Case Rep; 2023 Sep; 11(9):e7859. PubMed ID: 37720715 [TBL] [Abstract][Full Text] [Related]
4. Vincristine-ticlopidine-aspirin: an effective therapy in children with Kasabach-Merritt phenomenon associated with vascular tumors. Fernandez-Pineda I; Lopez-Gutierrez JC; Ramirez G; Marquez C Pediatr Hematol Oncol; 2010 Nov; 27(8):641-5. PubMed ID: 20863161 [TBL] [Abstract][Full Text] [Related]
5. Kasabach-Merritt Phenomenon: Classic Presentation and Management Options. Mahajan P; Margolin J; Iacobas I Clin Med Insights Blood Disord; 2017; 10():1179545X17699849. PubMed ID: 28579853 [TBL] [Abstract][Full Text] [Related]
6. Ultrasonography and magnetic resonance imaging features of kaposiform hemangioendothelioma and tufted angioma. Gong X; Ying H; Zhang Z; Wang L; Li J; Ding A; Zhou L; Lin X; Xiong P J Dermatol; 2019 Oct; 46(10):835-842. PubMed ID: 31373042 [TBL] [Abstract][Full Text] [Related]
7. Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey. Tlougan BE; Lee MT; Drolet BA; Frieden IJ; Adams DM; Garzon MC J Pediatr Hematol Oncol; 2013 Nov; 35(8):618-22. PubMed ID: 23774156 [TBL] [Abstract][Full Text] [Related]
8. Treatment experience for different risk groups of Kaposiform hemangioendothelioma. Li M; Wang X; Kieran R; Sun ZW; Gong Y; Lei H; Sun B; Xiao L; Wang Y; Wang S; Li Z; Wang L; Lv R; Xue F; Ge J; Dong C; Huo R Front Oncol; 2024; 14():1336763. PubMed ID: 38903724 [TBL] [Abstract][Full Text] [Related]
9. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon in an infant: Successful treatment with prednisolone, vincristine, and addition of sirolimus. Cashell J; Smink GM; Helm K; Xavier F Pediatr Blood Cancer; 2018 Dec; 65(12):e27305. PubMed ID: 30070028 [TBL] [Abstract][Full Text] [Related]
10. A not so harmless mass: Kaposiform hemangioendothelioma complicated by a Kasabach-Merritt phenomenon. Tribolet S; Hoyoux C; Boon LM; Cheruy C; Demarche M; Jamblin P; Roberti A; Willemaers V; Viellevoye R; Rigo V; Broux I Arch Pediatr; 2019 Sep; 26(6):365-369. PubMed ID: 31353149 [TBL] [Abstract][Full Text] [Related]
11. Kaposiform hemangioendothelioma: atypical features and risks of Kasabach-Merritt phenomenon in 107 referrals. Croteau SE; Liang MG; Kozakewich HP; Alomari AI; Fishman SJ; Mulliken JB; Trenor CC J Pediatr; 2013 Jan; 162(1):142-7. PubMed ID: 22871490 [TBL] [Abstract][Full Text] [Related]
12. The clinical spectrum of kaposiform hemangioendothelioma and tufted angioma. Croteau SE; Gupta D Semin Cutan Med Surg; 2016 Sep; 35(3):147-52. PubMed ID: 27607323 [TBL] [Abstract][Full Text] [Related]
13. Case report: Experience of a rare case of rebound of the Kasabach-Merritt phenomenon during sirolimus treatment in kaposiform hemangioendothelioma. Wang L; Li J; Wu C; Song D; Liu Z; Niu Y; Zhou J; Guo L Front Pediatr; 2022; 10():949950. PubMed ID: 35990005 [TBL] [Abstract][Full Text] [Related]
14. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon in a Neonate - Role of Dual Therapy: A Case Report and Review of Literature. Parashar G; Shankar G; Sahadev R; Santhanakrishnan R J Indian Assoc Pediatr Surg; 2020; 25(3):178-181. PubMed ID: 32581448 [TBL] [Abstract][Full Text] [Related]
15. Kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon. Gruman A; Liang MG; Mulliken JB; Fishman SJ; Burrows PE; Kozakewich HP; Blei F; Frieden IJ J Am Acad Dermatol; 2005 Apr; 52(4):616-22. PubMed ID: 15793511 [TBL] [Abstract][Full Text] [Related]
16. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up. Wang Z; Li K; Yao W; Dong K; Xiao X; Zheng S Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262 [TBL] [Abstract][Full Text] [Related]
17. Musculoskeletal complication in kaposiform hemangioendothelioma without Kasabach-Merritt phenomenon: clinical characteristics and management. Ji Y; Yang K; Chen S; Peng S; Lu G; Liu X Cancer Manag Res; 2018; 10():3325-3331. PubMed ID: 30233248 [TBL] [Abstract][Full Text] [Related]
18. Kaposiform Hemangioendothelioma with Kasabach-Merritt Phenomenon. Pati S; Das MK; Rana A; Das E; Sarkar S; Sherpa N; Datta S Indian J Pediatr; 2021 Nov; 88(11):1142-1144. PubMed ID: 34106442 [TBL] [Abstract][Full Text] [Related]
19. Kasabach-Merritt phenomenon in Chinese children: Report of 19 cases and brief review of literature. Yuan SM; Shen WM; Chen HN; Hong ZJ; Jiang HQ Int J Clin Exp Med; 2015; 8(6):10006-10. PubMed ID: 26309243 [TBL] [Abstract][Full Text] [Related]
20. Development of Kasabach-Merritt phenomenon following vaccination: More than a coincidence? Ji Y; Chen S; Yang K; Xia C; Peng S J Dermatol; 2018 Oct; 45(10):1203-1206. PubMed ID: 30118141 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]